Back in the late 1960s and early 1970s, psychedelics drugs like LSD were still legal and could be researched.
But in 1968 when the federal government criminalized them, a lot of promising research stopped.
Now the spotlight is back on these drugs and the success they’ve shown in clinical trials for treating a range of mental health conditions.
This is not only great news for people suffering from these conditions, but also for savvy investors who’ll get in on the ground floor of a market that could be worth more than $29 billion by the end of the decade.
Here’s Shah with all the details….